1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
IGROV-1 ovary CTRPv22
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZER1 CTRPv2 AAC -0.17 9e-06
mRNA PYURF CTRPv2 AAC 0.17 9e-06
mRNA RABIF CTRPv2 AAC 0.17 9e-06
mRNA EXOSC8 CTRPv2 AAC 0.18 1e-05
mRNA LAMA5 CTRPv2 AAC -0.19 1e-05
mRNA PRIMPOL CTRPv2 AAC 0.17 1e-05
mRNA CREBRF CTRPv2 AAC -0.16 1e-05
mRNA LTV1 CTRPv2 AAC 0.16 2e-05
mRNA PIGY CTRPv2 AAC 0.16 2e-05
mRNA DTL CTRPv2 AAC 0.17 2e-05
Download CSV